| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b01dcd61775e996fac631d4b10c4e87f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3b4f2ef8f062dcde3a2b7cd81748472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed3c2f63a5b1c705b1b389a6f1f1f7c8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6862
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57419 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-30 |
| filingDate |
2017-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a6069f3f1411fed0ea1989fda9ade89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d19cd2d20ab761d50d12850103a2493
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba5c02f9d8c57e99b1de9802a1574857 |
| publicationDate |
2021-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2808004-T3 |
| titleOfInvention |
Methods for Classifying Patients with Solid Cancer |
| abstract |
An in vitro method for the prognosis of the survival time of a patient suffering from a solid cancer, which method comprises the following steps: a) detect and quantify two or more biological markers indicative of the state of the immune response of said patient against said cancer , wherein each biological marker indicative of the state of the immune response is detected in vitro and quantified in a tumor sample obtained from said patient; b) comparing each value obtained in step a) for said two or more biological markers with a distribution of values obtained for each of said two or more biological markers from a reference group of patients suffering from said cancer; c) determining for each value obtained in step a) for said two or more biological markers the percentile of the distribution to which the values obtained in step a) correspond; d) calculating the arithmetic mean value or the mean value of the percentiles of the biological markers determined in step c); and e) comparing the arithmetic mean value or the mean value of percentiles obtained in step d) with a predetermined reference arithmetic mean value or a predetermined mean value of percentiles, the predetermined reference value of which is correlated with the survival time. |
| priorityDate |
2016-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |